We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
-0.73%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$21B
AUM Growth
-$562M
Cap. Flow
-$305M
Cap. Flow %
-1.45%
Top 10 Hldgs %
43.23%
Holding
256
New
8
Increased
47
Reduced
126
Closed
11

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$92M
2
GILD icon
Gilead Sciences
GILD
+$86.1M
3
CB icon
Chubb
CB
+$11.5M
4
EOG icon
EOG Resources
EOG
+$8.76M
5
STT icon
State Street
STT
+$7.72M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$55.5M
2
AAPL icon
Apple
AAPL
+$32.3M
3
GE icon
GE Aerospace
GE
+$32.1M
4
XOM icon
ExxonMobil
XOM
+$31.5M
5
KMI icon
Kinder Morgan
KMI
+$22.7M

Sector Composition

Rank Sector Weight
1 Consumer Staples 27.96%
2 Energy 25.29%
3 Financials 12.53%
4 Healthcare 10.76%
5 Technology 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWH
101
DELISTED
Allied World Assurance Co Hld Lt
AWH
$5.4M 0.03%
157,020
CNQ icon
102
Canadian Natural Resources
CNQ
$96.9B
$5.13M 0.02%
276,672
-7,426
-3% -$126K
OKS
103
DELISTED
Oneok Partners LP
OKS
$4.82M 0.02%
90,034
+7,995
+10% +$425K
CL icon
104
Colgate-Palmolive
CL
$74.8B
$4.53M 0.02%
69,751
-4,754
-6% -$300K
HON icon
105
Honeywell
HON
$76.4B
$4.19M 0.02%
50,277
+896
+2% +$74.2K
SLB icon
106
SLB Ltd
SLB
$72.7B
$4.02M 0.02%
41,243
-2,302
-5% -$208K
NFX
107
DELISTED
Newfield Exploration
NFX
$3.81M 0.02%
121,375
+22,299
+23% +$589K
TPR icon
108
Tapestry
TPR
$30.3B
$3.61M 0.02%
72,608
-397
-0.5% -$19.8K
SJM icon
109
J.M. Smucker
SJM
$13.5B
$3.55M 0.02%
36,536
-2,010
-5% -$195K
GOOG icon
110
Alphabet (Google) Class C
GOOG
$4.11T
$3.1M 0.01%
111,858
+5,220
+5% +$152K
KEX icon
111
Kirby Corp
KEX
$7.01B
$2.64M 0.01%
26,100
LEG icon
112
Leggett & Platt
LEG
$1.4B
$2.61M 0.01%
80,000
TCBI icon
113
Texas Capital Bancshares
TCBI
$4.28B
$2.6M 0.01%
40,000
EMR icon
114
Emerson Electric
EMR
$81.6B
$2.33M 0.01%
34,949
-440
-1% -$29K
GRFS
115
Grifois
GRFS
$5.55B
$2.3M 0.01%
111,452
NWS icon
116
News Corp Class B
NWS
$17.7B
$2.28M 0.01%
136,563
-3,256
-2% -$55.3K
HES
117
DELISTED
Hess
HES
$2.16M 0.01%
26,050
+70
+0.3% +$5.56K
PNY
118
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$2.12M 0.01%
59,840
TK icon
119
Teekay
TK
$996M
$2.11M 0.01%
37,500
SYY icon
120
Sysco
SYY
$40.8B
$1.96M 0.01%
54,265
+4,698
+9% +$169K
RL icon
121
Ralph Lauren
RL
$22.4B
$1.92M 0.01%
11,935
-500
-4% -$80.6K
DUK icon
122
Duke Energy
DUK
$101B
$1.92M 0.01%
26,963
+422
+2% +$29.4K
LLY icon
123
Eli Lilly
LLY
$1.08T
$1.84M 0.01%
31,321
-341
-1% -$19K
GIS icon
124
General Mills
GIS
$20.2B
$1.72M 0.01%
33,245
+3,058
+10% +$151K
RDS.B
125
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$1.69M 0.01%
21,658

Similar funds

Fayez Sarofim & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Fayez Sarofim & Co held 256 positions worth $21B, down 2.6% from $21.5B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co's Q1 2014 filing shows 8 new, 47 increased, 126 reduced and 11 closed positions. Its largest new stake was Gilead Sciences: 1,098,306 shares worth $78.4M. The largest sale was Intuitive Surgical, an estimated $55.5M.

By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, down from 29% a quarter earlier, followed by Energy and Financials.

  • Fayez Sarofim & Co's largest Q1 2014 buy was Gilead Sciences: 1,098,306 shares worth $78.4M.
  • Fayez Sarofim & Co added most to Union Pacific in Q1 2014, an estimated $92M increase.
  • Fayez Sarofim & Co's biggest Q1 2014 reduction was Intuitive Surgical, cutting an estimated $55.5M.
  • Fayez Sarofim & Co fully exited State Street SPDR S&P 500 ETF Trust in Q1 2014, selling an estimated $3.03M.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $21B portfolio in Q1 2014.
  • Fayez Sarofim & Co opened 8 new positions and closed 11 in Q1 2014.
  • Fayez Sarofim & Co's portfolio value fell 2.6% quarter-over-quarter to $21B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2014, filed 14 May 2014.